Non-alcoholic Fatty Liver Disease (NAFLD)
Conditions
Brief summary
Non-alcoholic fatty liver disease (NAFLD) is currently the most common chronic liver disease, with an estimated prevalence of 5-30% in the general population and 55-80% in patients with type 2 diabetes. Methods for the quantitative and non-invasive assessment of liver fat content have recently been implemented on ultrasound devices, based on the estimation of the ultrasound beam attenuation coefficient and backscattering. These methods are CE marked and already commercially available. The aim of the study is to compare the results of the degree of steatosis detected by different ultrasound devices with the degree of steatosis of the CAP (Controlled Attenuation Parameter) module implemented on the Fibroscan machine.
Interventions
DEVICECAP (Controlled Attenuation Parameter) module implemented on the Fibroscan machine.
Use of the CAP module implemented on the Fibroscan machine to compare the results of the degree of steatosis
Sponsors
Fondazione IRCCS Policlinico San Matteo di Pavia
Study design
Observational model
COHORT
Time perspective
PROSPECTIVE
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
* age \> 18 years, * ability to hold breath for image acquisition, * informed consent
Exclusion criteria
* withdrawal of informed consent, * any condition which, in the clinical judgement of the investigator, will make further participation in the study unacceptable for that individual patient
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Comparison of the results relating to the degree of steatosis detected by the various ultrasound devices with the CAP module | 05 May 2025 |
Countries
Italy
Outcome results
None listed